洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2000033174】A Multicentre Randomized Controlled Trial Comparing Plating with Intramedullary Nailing for Extra-articular Distal Tibial Fractures

基本信息
登记号

ChiCTR2000033174

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-05-23

临床申请受理号

/

靶点

/

适应症

关节外Pilon骨折

试验通俗题目

A Multicentre Randomized Controlled Trial Comparing Plating with Intramedullary Nailing for Extra-articular Distal Tibial Fractures

试验专业题目

A Multicentre Randomized Controlled Trial Comparing Plating with Intramedullary Nailing for Extra-articular Distal Tibial Fractures

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

75500

联系人通讯地址
请登录查看
临床试验信息
试验目的

In this multicentre randomised controlled trial we aim to assess ratings of disability 6?months postinjury in patients who have sustained a distal tibia fracture treated with either an intramedullary nail or plate and locking screw fixation. The primary objective is: To quantify and draw inferences on observed differences in the DRI between the trial treatment groups at 6 months after injury. The secondary objectives are: To quantify and draw inferences on observed differences in early functional status at 3 months and later functional status at 12 months. To quantify and draw inferences on observed differences in the radiological outcomes: non-union, mal-alignment and shortening. To identify any differences in health-related quality of life between the trial treatment groups in the first year after injury. To determine the complication rate of intramedullary nail fixation versus locking plate fixation in the first year after injury.

试验分类
请登录查看
试验类型

半随机对照

试验分期

其它

随机化

The method of fixation will be allocated using a secure, centralised, web-based randomisation service. The randomisation service will be available 24 h each day to facilitate the inclusion of all eligible patients.

盲法

As the type of fixation used requires clearly visible surgical scars, the patients cannot be blind to their treatment. In addition, the treating surgeons will also not be blind to the treatment, but will take no part in the postoperative assessment of the patients. The functional outcome data will be collected and entered into the trial central database via questionnaire by a research assistant/data clerk in the trial central office. The X-rays collected will be reviewed by an independent assessor.

试验项目经费来源

Nil

试验范围

/

目标入组人数

242;233

实际入组人数

/

第一例入组时间

2015-10-16

试验终止时间

2019-03-20

是否属于一致性

/

入选标准

Patients will be eligible for this study if: Aged 16 years or over; Patients with a fracture that involves the distal tibial metaphysisdefined as a fracture extending within 2 Müller squares of the ankle joint21are eligible if: The fracture is closed; In the opinion of the attending surgeon, the patient would benefit from internal fixation of the fracture.;

排除标准

Patients will be excluded from participation in this study if: In the opinion of the attending surgeon, there is a contraindication to intramedullary nailing; The fracture is open; There is a contra-indication to anaesthesia; There is evidence that the patient would be unable to adhere to trial procedures or complete questionnaires The fracture extends into the ankle joint (ie, intra-articular fracture). Contraindications to intramedullary nailing are: the medullary canal is too narrow OR there is a preinjury deformity of the medullary canal OR it is not possible to achieve fixation of four cortices with screws distal to the fracture. We feel that these exclusion criteria will be easily understood by the surgeons and are in keeping with the pragmatic nature of the trial. However, we will include the specific reason in the trial screening data. For those patients withdrawing from the trial after written consent has been obtained, data obtained up until the point of withdrawal will be included in the final analysis.;

研究者信息
研究负责人姓名
请登录查看
试验机构

巴基斯坦拉合尔古尔基信托和教学医院

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

75500

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用